Indian Health Outcomes, Public Health and Economics Research Centre (IHOPE) Read More
Clinical Research
LVPEI has been successfully audited by United States - Food and Drug Administration Agency (US FDA) and European Medicine Agency (EMA) for performing clinical trials.
Raja Narayanan, Director, Clinical Research
Contact: 040 68102618
Mail: narayanan@lvpei.org
Kallam Anji Reddy Campus
Administrator: T. Charitha
Study Coordinators: Vijaya, Ramya, Kalpana, Kavya
Study Optometrist: Manindra, Subba Rao
Contact Numbers (Clinical Research): 040-68102123/2124
Image reading centre:
Graders: Renuka Sai
Contact Number: 040-6810 2170
Bhubaneswar Campus-Clinical Research
Clinical Research Coordinators: Asit, Suprateeka, Rojalin, SatyaPrakash
Ethics Committee Coordinator: Mohammed Hasibur Rahman
Study Optometrists: Kartik Jana
Contact Number: 06740 2653261
GMRV Campus-Clinical Research
Clinical Research Coordinator: Sumitra, Aishwarya
Contact Number: 9515263101 / 9182211204
KAR CAMPUS |
|||||
---|---|---|---|---|---|
S.No | Name of the project | Principal Investigator | Supported By | Duration | CTRI |
1 | Prospective, Investigator Initiated study to evaluate, biocompatibility and indicative effectiveness of the Endo Art in subjects having corneal edema with no visual potential | Dr.Sunita Chaurasia | EYEYON | 2021-2023 | http://ctri.nic.in |
2 | Prospective, Investigator Initiated Study to Evaluate the Safety, and Indicative Effectiveness of Xenia™ in Subjects Having Keratoconus | Dr.Pravin Krishna | Gebauer | 2021-2023 | http://ctri.nic.in |
3 | Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (FOCUS) | Dr.Padmaja Kumari | Novanordisk | 2020-2025 | http://ctri.nic.in |
4 | A Double Masked, Parallel Group, Randomized, Multicenter, Clinical Study to Compare Efficacy and Safety of Intas Ranibizumab with Lucentis@ in Patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD)" | Dr.Raja Narayanan | Dr.Raja Narayanan | 2021-2023 | http://ctri.nic.in |
5 | A real-world, prospective, multi-center, open-label, phase IV clinical study to evaluate the safety and effectiveness of intravitreal injections (IVI) of brolucizumab in patients with neovascular age-related macular degeneration (nAMD). | Dr.Vishal Raval | Novartis | 2022-2023 | http://ctri.nic.in |
6 | A phase 3 multicentre, double masked, Randomised, study to evaluate the efficacy and safety of intravitreal OPT-302 in combination with Aflibercept, compared with Aflibercept alone in patients with neovascular age related macular degeneration. | Dr.Brijesh Takkar | IQVIA | 2022-2023 | http://ctri.nic.in |
7 | Multi-Parameter Analysis of Tear Film of Healthy and Suspected Dry Eye Patients using TeaRx Non-Invasive Point-of-care Testing Device: An Investigator Initiated Academic Trial | Dr.Sayan Basu | Diagnostear | 2021-2023 | http://ctri.nic.in |
8 | A Phase IV interventional post approval trial to assess the safety of intravitreal aflibercept for the treatment of diabetic macular edema (DME) in patients in India. | Dr.Vishal Raval | Bayer | 2022-2023 | http://ctri.nic.in |
9 | A randomized double masked parallel group multicenter clinical study to evaluate efficacy and safety of AVT 06 compared with EU-Eylea in subjects with neovascular Wet) age related macular degeneration (ALVOEYE) | Dr.Vivek Dave | ALVOTEC | 2023-2024 | http://ctri.nic.in |
BBSR CAMPUS |
|||||
---|---|---|---|---|---|
S.No | Name Of The Project | Principal Investigator | Supported By | Duration | CTRI |
1 | A phase 3 multicentre, double masked, Randomised, study to evaluate the efficacy and safety of intravitreal OPT-302 in combination with Aflibercept, compared with Aflibercept alone in patients with neovascular age related macular degeneration. | Dr.Tapas Ranjan | IQVIA | 2022-2023 | http://ctri.nic.in |
2 | A Randomized, Active-Controlled, Double-Masked, Parallel-Group, Phase 3 Study to Compare Efficacy and Safety of CT-P42 in comparison with Eylea in Patients with Diabetic Macular Edema. | Dr.Umesh Chandra | Syneos Health | 2021-2023 | http://ctri.nic.in |
3 | A Phase 2, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution Compared to Placebo in the Treatment of Adenoviral Conjunctivitis | Dr.Sujata Das | INNVOCEPT | 2023-2024 | https://clinicaltrials.gov |
GMRV CAMPUS |
|||||
---|---|---|---|---|---|
S.No | Name of the Project | Principal Investigator | Supported By | Duration | CTRI |
1 | A Randomized, Active-Controlled, Double-Masked, Parallel-Group, Phase 3 Study to Compare Efficacy and Safety of CT-P42 in comparison with Eylea in Patients with Diabetic Macular Edema. | Dr.Bhavik Panchal | Syneos Health | 2021-2023 | http://ctri.nic.in |